Identification of Galectin-3 and Mucin-Type O-Glycans in Breast Cancer and Its Metastasis to Brain

REFERENCES

• Hakomori S. Glycosylation defining cancer malignancy: New wine in an old bottle. PNAS 2002; 99: 10231–10233
   PubMed Web of Science ®Google Scholar
• Couldrey C., Green J. E. Metastases: the glycan connection. Breast Cancer Res 2000; 2: 321–323
   PubMed Web of Science ®Google Scholar
• Springer G. F., Desai P. R., Ghazizadeh M., Tegmeyer H. T/Tn pancarcinoma autoantigens: fundamental, diagnostic and prognostic aspects. Cancer Detect Prev 1995; 19: 173–182
   PubMedGoogle Scholar
• Springer G. F. T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy. Crit Rev Oncogen 1995; 6: 57–85
   PubMed Web of Science ®Google Scholar
• Van den Steen P., Rudd P. M., Dwek R. A., Openakker G. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 1998; 33: 151–208
   PubMed Web of Science ®Google Scholar
• Martensson S., Levery S. B., Fang T. T., Bendiak B. Neutral core oligosaccharides of bovine submaxillary mucin: use of lead tetraacetate in the cold for establishing branch positions. Eur J Biochem 1998; 258: 603–622
   PubMedGoogle Scholar
• Fonseca I., Costa Rosa J., Felix A., Therkildsen M. H., Soares J. Simple mucin-type carbohydrate antigens (T, Tn, and sialosyl-Tn) in mucoepidermoid carcinoma of the salivary glands. Histopathol 1994; 25: 537–543
   PubMed Web of Science ®Google Scholar
• Cao Y., Stosiek P., Springer G. F., Karsten U. Thomsen Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem. Cell Biol 1996; 106: 197–207
   PubMed Web of Science ®Google Scholar
• Glinsky V. V., Huflejt M. E., Glinsky G. V., Deutscher S. L., Quinn T. P. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 2000; 60: 2584–2588
   PubMed Web of Science ®Google Scholar
• Lis H., Sharon N. Lectins as molecules and as tools. Ann Rev Biochem 1986; 55: 35–67
   PubMed Web of Science ®Google Scholar
• Raz A., Lotan R. Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 1987; 6: 433–452
   PubMed Web of Science ®Google Scholar
• Zou J., Glinsky V. V., Landon L. A., Matthews L., Deutscher S. L. Peptides specific to the Galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogen 2005; 26: 309–318
   PubMed Web of Science ®Google Scholar
• Shigeoka H., Karsten U., Okuno K., Yasutomi M. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody. Tumour Biol 1999; 20: 139–146
   PubMed Web of Science ®Google Scholar
• Takenaka Y., Fukumori T., Raz A. Galectin-3 and metastasis. Glycoconj J 2004; 19: 453–549
   Google Scholar
• Le Marer N., Hughes R. C. Effects of the carbohydrate-binding protein Galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 1996; 168: 51–58
   PubMed Web of Science ®Google Scholar
• Matarrese P., Fusco O., Tinari N., Natoli C., Ciu F. T., Semeraro M. L., et al. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 2000; 85: 545–554
   PubMed Web of Science ®Google Scholar
• Zenteno E., Ochoa J. L. Isolation and purification of Amaranthus leucocarpus lectin on stroma column. Phytochem 1988; 27: 313–317
   Web of Science ®Google Scholar
• Zenteno E., Debray H., Montreuil J. Purification and partial characterization of two lectins from the cactus Machaerocereus eruca. FEBS Letters 1988; 238: 95–100
   PubMed Web of Science ®Google Scholar
• Avidin-biotin chemistry: A handbook, D. Savage, G. Mattson, S. Desai, G. Nielander, S. Morgensen, E. Conklin. Pierce Chemical Company, Rockford, ILUSA 1992
   Google Scholar
• Guevara J., Espinosa B., Zenteno E., Vasquez L., Luna J., Perry G., Mena R. Altered glycosylation pattern in Alzheimer disease. J Neuropathol Exp Neurol 1998; 57: 905–914
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts and Figures 2007. American Cancer Society, Atlanta, GA 2007
   Google Scholar
• Steeg P. S. Molecular biology of breast cancer metastasis ‘Has it spread?’: disarming one of the most terrifying questions. Breast Cancer Res 2000; 2: 396–399
   PubMed Web of Science ®Google Scholar
• Hsiung R., Zhu W., Klein G., Qin W., Rosenberg A., Park P., et al. High basic fibroblast growth factors levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 2002; 8: 303–310
   PubMed Web of Science ®Google Scholar
• Foretova L., Garber J. E., Sadowsky N. L., Verselis S. J., Joseph Andrade D. M. A. F. F., et al. Carcinoembryonic antigen in breast nipple aspirate fluid. Cancer Epidem Biom Prev 1998; 7: 195–198
   PubMed Web of Science ®Google Scholar
• Kumar S. R., Sauter E. R., Quinn T. P., Deutscher S. L. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Clin Cancer Res 2005; 11: 6868–6871
   PubMed Web of Science ®Google Scholar
• Hernandez P., Tetaert D., Vergoten G., Debray H., del Carmen Jimenez M., Fernandez G., Agundis C., et al. Specificity of Amaranthus leucocarpus synhypocondriacus lectin for O-glycopeptides. Biochim Biophys Acta 2004; 1674: 282–290
   PubMed Web of Science ®Google Scholar
• Yuan M., Itzkowitz S. H., Boland C. R., Kim Y. D., Tomita J. T., Palekar A., et al. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Cancer Res 1986; 46: 4841–4847
   PubMed Web of Science ®Google Scholar
• Irazoqui F. J., Jansson B., Lopez P. H. H., Nores G. A. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation. J Biochem 2001; 130: 33–37
   PubMed Web of Science ®Google Scholar
• Wang B. L., Springer G. F., Carlstedt S. C. Quantitative computerized image analysis of Tn and T (Thomsen-Friedenreich) epitopes in prognostication of human breast carcinoma. J Histochem Cytochem 1997; 45: 1393–1400
   PubMed Web of Science ®Google Scholar
• Baldus S. E., Zirbes T. K., Hanisch F. G., Kunze D., Shafizadeh S. T., Nolden S., et al. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma. A clinicopathologic study of 264 patients. Cancer 2000; 88: 1536–1543
   PubMed Web of Science ®Google Scholar
• Cao Y., Karsten U., Otto G., Bannasch P. Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha 2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Archiv 1999; 434: 503–509
   PubMed Web of Science ®Google Scholar
• Schindlbeck C., Jeschke U., Schulze S., Karsten U., Janni W., Rack B, et al. Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients. Breast Cancer Res Treat 2007; 101: 17–25
   PubMed Web of Science ®Google Scholar
• Lotan R., Skutelsky E., Danon D., Sharon N. The purification, composition and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975; 250: 8518–8523
   PubMed Web of Science ®Google Scholar
• Zenteno E., Vazquez L., Chavez R., Cordoba F., Wieruszeski J. M., Montreuil J., Debray H. Specificity of the isolectins from the plant cactus Machaerocereus eruca for oligosaccharides from porcine stomach mucin. Glycoconj J 1995; 12: 699–706
   PubMed Web of Science ®Google Scholar
• Laferte S., Chan N. W., Sujino K., Lowary T. L., Palcic M. M. Intracellular inhibition of blood group A glycosyltransferase. Eur J Biochem 2000; 267: 4840–4849
   PubMedGoogle Scholar
• Meromzky L., Lotan R., Raz A. Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res 1986; 46: 5270–5275
   PubMed Web of Science ®Google Scholar
• Pacis R. A., Pilat M. J., Pienta K. J., Wojno K., Raz A., Hogan V., Cooper C. R. Decreased galectin-3 expression in prostate cancer. Prostate 2000; 44: 118–123
   PubMed Web of Science ®Google Scholar
• Lotz M. M., Andrews C. W., Jr., Korzelius C. A., Lee E. C., Steele G. D., Jr., Clarke A., Mercurio A. M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. PNAS 1993; 90: 3466–3470
   PubMed Web of Science ®Google Scholar
• Castronovo V., Campo E., van den Brule F. A., Claysmith A. P., Cioce V., Liu F. T., Fernandez P. L., Sobel M. E. Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992; 84: 1161–1169
   PubMed Web of Science ®Google Scholar
• Castronovo V., van den Brule F. A., Jackers P., Clausse N., Liu F. T., Gillet C., Sobel M. E. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 1996; 179: 43–48
   PubMed Web of Science ®Google Scholar
• Idikio H. Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade. Int J Oncol 1998; 12: 1287–1290
   PubMed Web of Science ®Google Scholar
• Nangia-Makker P., Thompson E., Hogan C., Ochieng J., Raz A. Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell-line. Int J Oncol 1995; 7: 1079–1087
   PubMed Web of Science ®Google Scholar
• Honjo Y., Nangia-Makker P., Inohara H., Raz A. Down regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 2001; 7: 661–668
   PubMed Web of Science ®Google Scholar
• Bresalier R. S., Mazurek N., Sternberg L. R., Byrd J. C., Yunker C. K., Nangia-Makker P., Raz A. Metastasis of human colon cancer is altered by modifying expression of the β-galactose-binding protein galectin-3. Gastroenterology 1998; 115: 287–296
   PubMed Web of Science ®Google Scholar
• Meyer J. S. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986; 7: 171–180
   PubMed Web of Science ®Google Scholar
• Lagios M. D., Westdahl P. R., Margolin F. R., Rose M. R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 1309–1314
   PubMed Web of Science ®Google Scholar
• Nangia-Makker P., Sarvis R., Visscher D. W., Bailey-Penrod J., Raz A., Sarkar F. H. Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat 1998; 49: 171–183
   PubMed Web of Science ®Google Scholar
• Le Marer N., Hughes R. C. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 1996; 168: 51–58
   PubMed Web of Science ®Google Scholar
• Shekhar M. P. V., Nangia-Makker P., Tait L., Miller F., Raz A. Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions. Am J Pathol 2004; 165: 1931–1941
   PubMed Web of Science ®Google Scholar
• Baptiste T. A., James A., Saria M., Ochieng J. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. Exp Cell Res 2007; 313: 652–664
   PubMed Web of Science ®Google Scholar
• Song Y. K., Billiar T. R., Lee Y. J. Role of galectin-3 in breast cancer metastasis. Involvement of Nitric Oxide. Am J Pathol 2002; 160: 1069–1075
   PubMed Web of Science ®Google Scholar
• Hsu D. K., Dowling C. A., Jeng K. C., Chen J. T., Yang R. Y., Liu F. T. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999; 17: 519–526
   Google Scholar
• Hoyer K. K., Pang M., Gui D., Shintaku I. P., Kuwabara I., Liu F. T., Said J. W., Baum L. G., Teitell M. A. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 2004; 164: 893–902
   PubMed Web of Science ®Google Scholar
• Glinsky V. V., Glinsky G. V., Rittenhouse-Olson K., Huflejt M. E., Glinskii O. V., Deutscher S. L., Quinn T. P. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 2001; 61: 4851–4857
   PubMed Web of Science ®Google Scholar
• Hanisch F. G. O-glycosylation of the mucin-type. Biol Chem 2001; 382: 143–149
   PubMed Web of Science ®Google Scholar
• Pratt M. R., Hang H. C., Ten Hagen K. G., Rarick J., Gerken T. A., Tazbak L. A., Berotozzi C. R. Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. Chem Biol 2004; 11: 1009–1116
   PubMed Web of Science ®Google Scholar